Plasma Reticulocalbin 3 (RCN3) is a Novel Biomarker for the Early Diagnosis of Hepatopulmonary Syndrome in Cirrhotic PatientsFangping Ding, Jiawei Jin, Weiwei Kang et al.|Lung|2025Cited by 2
Predictive models and clinical manifestations of intrapulmonary vascular dilatation and hepatopulmonary syndrome in patients with cirrhosis: Prospective comparative studyZhipeng Wu, Yingmin Ma, Yingfei Wang et al.|World Journal of Gastroenterology|2025Cited by 1
SAT-548 Variations in dynamic T cell response are associated with the HCC recurrence treated with anti-PD-1 immunotherapy after interventional therapyYonghong Zhang, Yu Sun, Biyu Liu et al.|Journal of Hepatology|2024Cited by 0